Colossal

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.

Health and bioBoost VC

Latest funding

$120M Series B+ · September 18, 2025

Led by Breyer Capital · Source: bloomberg.com

Total raised: $380M across 3 sourced rounds

All 4 rounds ↓

Website: colossal.com.

X: @colossal · 337,643 followers.

LinkedIn: itiscolossal.

Category: Health and bio.

Sectors: Bio / Health.

Stage: Series B+.

Based in: Dallas, United States.

Founded: 2021.

Total raised: $380M in 3 sourced rounds.

Last round: Sep 18, 2025 · 423 days ago.

Headcount: 1–10 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@colossal · created Aug 19, 2021 (5 years old) · 337,643 followers

Website registeredApr 14, 1993 (33 years old)

About Colossal

Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction.

TIMELINE · MONEY RAISED

Colossal | 202 days from X account to first raise on record

@colossal·Raised $380M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Sep 18, 2025	Series B+	$120M	BBreyer Capital	bloomberg.com
Jan 15, 2025	Series B+	$200M	TTWG Global	businesswire.com
Mar 9, 2022	Series A	$60M	—	Business Wire

Timeline

August 19, 2021
X account created
Boost 2021
BBoost VC · batch
Source: boost.vc
April 14, 1993
Website created

Founders and team

BL
Ben Lamm Co-Founder and CEO

source: colossal.com
CJ
Christopher Jobson Founder

@itscolossal

Investors

Companies like Colossal

EElement Biosciences$175M Series B+ · Jun 2026
AAstromech$20M Seed · Aug 2026
AAmino Labs
QQuotient Therapeutics$50M Series B+ · Nov 2023
CCanal BiosciencesSeed · Apr 2026
BBIOMAKERSSeries A · Jul 2026

Other companies backed by Breyer Capital

WWarhound$200M · Oct 2026
SSoufflé Therapeutics$135M Series B+ · Oct 2026
OOpenEvidence$250M Series B+ · Sep 2026
OOnyx Odds$20M Series A · Jun 2026
NNesto$107M Series B+ · Jun 2026
CCatena$30M Series A · May 2026

Breyer Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/colossal (get a free API key).